Predicting lymph node metastasis in early colorectal cancer using the CITED1 expression.

[1]  J. C. Carlisle,et al.  POLYPS OF THE COLON: Late Results of Transcolonic Removal , 1953 .

[2]  W. Wolff,et al.  Definitive Treatment of “Malignant” Polyps of the Colon , 1975, Annals of surgery.

[3]  K. Forde,et al.  Endoscopic Polypectomy: lnadequa te Treatment for lnvasive Colorectal Carcinoma , 1981, Annals of surgery.

[4]  H. Cooper.  Surgical pathology of endoscopically removed malignant polyps of the colon and rectum , 1983, The American journal of surgical pathology.

[5]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[6]  C. Fenoglio-Preiser,et al.  Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential , 1989, Cancer.

[7]  L. Bégin,et al.  The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colectomy? , 1992, Cancer.

[8]  T. Minamoto,et al.  Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development. , 1993, The American journal of gastroenterology.

[9]  S. Kudo,et al.  Endoscopic Mucosal Resection of Flat and Depressed Types of Early Colorectal Cancer , 1993, Endoscopy.

[10]  C. R. Teixeira,et al.  Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. , 1995, Oncology.

[11]  R. Nozaki,et al.  Management of early invasive colorectal cancer , 1995, Diseases of the colon and rectum.

[12]  K. Isselbacher,et al.  msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Hirohashi,et al.  Cancer cell morphology at the invasive front and expression of cell adhesion‐related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis , 1996, Cancer.

[14]  K. Isselbacher,et al.  MSG1 and its related protein MRG1 share a transcription activating domain. , 1997, Gene.

[15]  E G Hahn,et al.  Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. , 1997, Endoscopy.

[16]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[17]  R. Beddington,et al.  Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis , 1998, Mechanisms of Development.

[18]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  K. Isselbacher,et al.  Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Isselbacher,et al.  The MSG1 Non-DNA-binding Transactivator Binds to the p300/CBP Coactivators, Enhancing Their Functional Link to the Smad Transcription Factors* , 2000, The Journal of Biological Chemistry.

[21]  T. Shioda,et al.  The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.

[22]  H. Ueno,et al.  Indicators for treatment strategies of colorectal liver metastases. , 2000, Annals of Surgery.

[23]  J. Hur,et al.  Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. , 2001, Genes & development.

[24]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Burgart,et al.  Risk of Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2002, Diseases of the colon and rectum.

[26]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[27]  S. Liyanarachchi,et al.  Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Catalin C. Barbacioru,et al.  CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study. , 2004, Thyroid : official journal of the American Thyroid Association.

[29]  Hidetaka Mochizuki,et al.  Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.

[30]  Y. Nakanishi,et al.  Predictive Histopathologic Factors for Lymph Node Metastasis in Patients With Nonpedunculated Submucosal Invasive Colorectal Carcinoma , 2005, Diseases of the colon and rectum.

[31]  S. Dunwoodie,et al.  Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  P. Kenny,et al.  ERα–CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis , 2007, Oncogene.

[33]  James R. Anderson,et al.  CITED1 expression in Wilms' tumor and embryonic kidney. , 2007, Neoplasia.

[34]  Y. Shyr,et al.  Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1. , 2007, Journal of pediatric surgery.

[35]  Y. Miki,et al.  Identification of the Molecular Mechanisms for Dedifferentiation at the Invasion Front of Colorectal Cancer by a Gene Expression Analysis , 2008, Clinical Cancer Research.